These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17728905)

  • 41. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
    Lai CH
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
    [No Abstract]   [Full Text] [Related]  

  • 42. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F
    Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.
    Egolf A; Coffey BJ
    Drugs Today (Barc); 2014 Feb; 50(2):159-79. PubMed ID: 24619591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Open label aripiprazole in the treatment of youth with tic disorders.
    Murphy TK; Mutch PJ; Reid JM; Edge PJ; Storch EA; Bengtson M; Yang M
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):441-7. PubMed ID: 19702496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.
    Barzman DH; DelBello MP; Kowatch RA; Gernert B; Fleck DE; Pathak S; Rappaport K; Delgado SV; Campbell P; Strakowski SM
    J Child Adolesc Psychopharmacol; 2004; 14(4):593-600. PubMed ID: 15662152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
    Brown ES; Jeffress J; Liggin JD; Garza M; Beard L
    J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
    Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
    Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report.
    Sharma V; Sommerdyk C; Xie B
    Arch Womens Ment Health; 2015 Feb; 18(1):131-4. PubMed ID: 25223952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aripiprazole for the treatment of Tourette syndrome.
    Cox JH; Cavanna AE
    Expert Rev Neurother; 2021 Apr; 21(4):381-391. PubMed ID: 33612035
    [No Abstract]   [Full Text] [Related]  

  • 58. A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder.
    Kim CY; Chung S; Lee JN; Kwon JS; Kim DH; Kim CE; Jeong B; Jeon YW; Lee MS; Jun TY; Jung HY
    Int Clin Psychopharmacol; 2009 Jul; 24(4):181-8. PubMed ID: 19451828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.
    Biederman J; McDonnell MA; Wozniak J; Spencer T; Aleardi M; Falzone R; Mick E
    CNS Spectr; 2005 Feb; 10(2):141-8. PubMed ID: 15685125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.